Proteolytic enzymes in inflammatory bowel disease

Inflammatory Bowel Diseases

Volumn 4, Issue 2, 1998, Pages 157-164

  MacDonald, Thomas T ^a   Pender, Sylvia L F ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PEPTIDE HYDROLASE;

ANIMAL; ENTERITIS; ENZYMOLOGY; FEMALE; HUMAN; INTESTINE MUCOSA; MALE; METABOLISM; REVIEW;

ANIMALS; FEMALE; HUMANS; INFLAMMATORY BOWEL DISEASES; INTESTINAL MUCOSA; MALE; PEPTIDE HYDROLASES;

EID: 0032063661     PISSN: 10780998     EISSN: None     Source Type: Journal    
DOI: 10.1002/ibd.3780040211     Document Type: Review

References (51)

1. Kraut J. Serine proteases: structure and mechanism of catalysis. Annu Rev Biochem 1977;46:331-58.
2. Saksela O, Rifkin DB. Cell-associated plasminogen activation: regulation and physiological functions. Annu Rev Cell Biol 1988; 4:93-126.
3. Salvesen G, Farley D, Shuman J, Przybyla A, Reilly C, Travis J. Molecular cloning of human cathepsin G: structural similarity to mast cell and cytotoxic T lymphocytes proteinases. Biochemistry 1987;26:2289-93.
4. Welle M. Development, significance, and heterogeneity of mast cells with particular regard to the mast cell-specific proteases chymase and tryptase. J Leukoc Biol 1997;61:233-45.
5. Barrett AJ, Buttle DJ, Mason RW. Lysosomal cysteine proteinases. Biochemistry 1988;1:256-60.
6. Baron R, Neff L, Louvard D, Courtoy PJ. Cell-mediated extracellular acidification and bone resorption: evidence for a low pH in resorbing lacunae and localization of a 100-kD lysosomal membrane protein at the osteoblast ruffled border. J Cell Biol 1985; 101:2210-22.
7. Silver IA, Murrills RJ, Etherington DJ. Microelectrode studies on the acid microenvironment beneath adherent macrophages and osteoclasts. Exp Cell Res 1988;175:266-76.
8. Delaisse JM, Boyde A, Maconnachie E, et al. The effects of inhibitors of cysteine-proteinases and collagenase on the resorptive activity of isolated osteoclasts. Bone 1987;8:305-13.
9. Burleigh MC. Degradation of collagen by non-specific proteinases. In: Barrett AJ, ed. Proteinases in mammalian cells and tissues. Amsterdam: Elsevier/North-Holland, 1977:285-309.
10. Mason RW, Taylor MAJ, Etherington DJ. The purification and properties of cathepsin L from rabbit liver. Biochem J 1984;217: 209-17.
11. Maciewicz RA, Wotton SF, Etherington DJ, Duance VC. Susceptibility of the cartilage collagens types II, IX and XI to degradation by the cysteine proteinases, cathepsins B and L. FEBS Lett 1990; 269:189-93.
12. Hofmann T, Dunn BM, Fink AL. Cryoenzymology of penicillopepsin; with an appendix: mechanism of action of aspartyl proteinases. Biochemistry 1984;23:5247-56.
13. Saftig P, Hetman M, Schmahl W, et al. Mice deficient for the lysosomal proteinase cathepsin D exhibit progressive atrophy of the intestinal mucosa and profound destruction of lymphoid cells. EMBO J 1995;14:3599-608.
14. Fields GB, Van Wart HE, Birkedal-Hansen H. Sequence specificity of human skin fibroblast collagenase. Evidence for the role of collagen structure in determining the collagenase cleavage site. J Biol Chem 1987;262:6221-6.
15. Seltzer JL, Eisen AZ, Bauer EA, Morris NP, Glanville RW, Burgeson RE. Cleavage of type VII collagen by interstitial collagenase and type IV collagenase (gelatinase) derived from human skin. J Biol Chem 1989;264:3822-6.
16. Mattei MG, Roeckel N, Olsen BR, Apte SS. Genes of the membrane-type matrix metalloproteinase (MT-MMP) gene family, MMP14, MMP15, and MMP16, localize to human chromosomes 14, 16, and 18 respectively. Genomics 1997;40:168-9.
17. Tomasek JJ, Halliday NL, Updike DL, Ahern-Moore JS, Vu TK, Liu RW, Howard EW. Gelatinase A activation is regulated by the organization of the polymerized actin cytoskeleton. J Biol Chem 1997;272:7482-7.
18. Stetler-Stevenson WG, Krutzsch HC, Wacher MP, Margulies IMK, Liotta LA. The activation of human type IV collagenase proenzyme: sequence identification of the major conversion product following organomercurial activation. J Biol Chem 1989;264: 1353-6.
19. Woessner JF Jr. Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J 1991;5:2145-54.
20. Birkedal-Hansen H, Moore WGI, Bodden MK, et al. Matrix metalloproteinases: a review. Crit Rev Oral Biol Med 1993;4:197-250.
21. Goetzl EJ, Banda MJ, Leppert D. Matrix metalloproteinases in immunity. J Immunol 1996;156:1-4.
22. Murphy G, Docherty AJP. The matrix metalloproteinases and their inhibitors. Am J Respir Cell Mol Biol 1992;7:120-5.
23. Adeyemi EO, Hodgson HJ. Faecal elastase reflects disease activity in active ulcerative colitis. Scand J Gastroenterol 1992;27:139-42.
24. Bailey CJ, Hembry RM, Alexander A, Irving MH, Grant ME, Shuttleworth CA. Distribution of the matrix metalloproteinases stromelysin, gelatinases A and B, and collagenase in Crohn's disease and normal intestine. J Clin Pathol 1994;47:113-6.
25. Saarialho-Kere UK, Vaalamo M, Puolakkainen P, Airola K, Parks WC, Karjalainen-Lindsberg ML. Enhanced expression of matrilysin, collagenase, and stromelysin-1 in gastrointestinal ulcers. Am J Pathol 1996;148:519-26.
26. Kofford MW, Schwartz LB, Schechter NM, Yager DR, Diegelmann RF, Graham MF. Cleavage of type I procollagen by human mast cell chymase initiates collagen fibril formation and generates a unique carboxyl-terminal peptide. J Biol Chem 1997;272:7127-31.
27. Stallmach A, Schuppan D, Riese HH, Matthes H, Riecken EO. Increased collagen type III synthesis by fibroblasts isolated from strictures of patients with Crohn's disease. Gastroenterology 1992; 102:1920-9.
28. Graham MF, Willey A, Adams J, Yager D, Diegelmann RF. Interleukin 1β downregulates collagen and augments collagenase expression in human intestinal smooth muscle cells. Gastroenterology 1996;110:344-50.
29. Murch SH, MacDonald TT, Walker-Smith JA, Levin M, Lionetti P, Klein NJ. Disruption of sulphated glycosaminoglycans in intestinal inflammation. Lancet 1993;341:711-4.
30. Anthony D, Savage F, Hembry R, Boulos P. Protease expression in experimental colitis. Agents Actions 1994;41(Special Conference Issue):C201-3.
31. Baragi VM, Qiu L, Gunja-Smith Z, Woessner JF Jr, Lesch CA, Guglietta A. Role of metalloproteinases in the development and healing of acetic acid-induced gastric ulcers in rats. Scand J Gastroenterol 1997;32:419-26.
32. Hattori K, Hirano T, Ushiyama C, et al. A metalloproteinase inhibitor prevents lethal acute graft-versus-host disease in mice. Blood 1997;90:542-8.
33. Scudamore CL, Thornton EM, McMillan L, Newlands GF, Miller HR. Release of the mucosal mast cell granule chymase, rat mast cell protease II, during anaphylaxis is associated with the rapid development of paracellular permeability to macromolecules in rat jejunum. J Exp Med 1995;182:1871-81.
34. Lionetti P, Breese E, Braegger CP, Murch SH, Taylor J, MacDonald TT. T cell activation can induce either mucosal destruction or adaptation in cultured human fetal small intestine. Gastroenterology 1993;105:373-81.
35. Pender SLF, Lionetti P, Murch SH, Wathan N, MacDonald TT. Proteolytic degradation of intestinal mucosal extracellular matrix after lamina propria T cell activation. Gut 1996;39:284-90.
36. Pender SLF, Tickle SP, Docherty AJP, Howie D, Wathen NC, MacDonald TT. A major role for matrix metalloproteinases in T cell injury in the gut. J Immunol 1997;158:1582-90.
37. Pender SLF, Fell JME, Chamow SM, Ashkenazi A, MacDonald TT. A p55 tumor necrosis factor (TNF) receptor immunoadhesin prevents T cell-mediated intestinal injury by inhibiting matrix metalloproteinase production. J Immunol 1998 (in press).
38. Targan SR, Hanauer SB, VanDeventer SJH, et al. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor α for Crohn's disease. N Engl J Med 1997;337:1029-35.
39. Breese EM, Braegger CP, Corrigan CJ, Walker-Smith JA, MacDonald TT. Interleukin-2 and interferon-gamma-secreting T cells in normal and diseased human intestinal mucosa. Immunology 1993;78:127-31.
40. Mullin GE, Lazenby AJ, Harris ML, Bayless TM, James SP. Increased interleukin-2 messenger RNA in the intestinal mucosal lesions of Crohn's disease but not ulcerative colitis. Gastroenterology 1992;102:1620-7.
41. Fuss IJ, Neurath M, Boirivant M, et al. Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. J Immunol 1996;157:1261-70.
42. Mahida YR, Wu K, Jewell DP. Enhanced production of interleukin-1β by mononuclear cells isolated from mucosa with active ulcerative colitis or Crohn's disease. Gut 1989;30:835-8.
43. Breese EJ, Michie CA, Nicholls SW, et al. Tumour necrosis factor-alpha producing cells in the intestinal mucosa of children with inflammatory bowel disease. Gastroenterology 1994;106:1455-66.
44. Viscardi RM, Lyon NH, Sun CC, Hebel JR, Hasday JD. Inflammatory cytokine mRNAs in surgical specimens of necrotising enterocolitis and normal newborn intestine. Pediatr Pathol Lab Med 1997;17:547-59.
45. Raqib R, Ljungdahl A, Lindberg AA, Wretlind B, Andersson U, Andersson J. Dissociation between cytokine mRNA expression and protein production in shigellosis. Eur J Immunol 1996;26: 1130-8.
46. Miltenburg AM, Lacraz S, Welgus HG, Dayer JM. Immobilized anti-CD3 antibody activates T cell clones to induce the production of interstitial collagenase, but not tissue inhibitor of metalloproteinases, in monocytic THP-1 cells and dermal fibroblasts. J Immmunol 1995;154:2655-67.
47. Suzuki K, Lees M, Newlands GF, Nagase H, Woolley DE. Activation of precursors for matrix metalloproteinases 1 (interstitial collagenase) and 3 (stromelysin) by rat mast-cell proteinases I and II. Biochem J 1995;305:301-6.
48. Okada Y, Nakanishi I. Activation of matrix metalloproteinase 3 (stromelysin) and matrix metalloproteinase 2 (gelatinase) by human neutrophil elastase and cathepsin G. FEBS Lett 1989;249: 353-6.
49. Murphy G, Cockett MI, Stephens PE, Smith BJ, Docherty AJP. Stromelysin is an activator of procollagenase, a study with natural and recombinant enzymes. Biochem J 1987;8:248-65.
50. Murphy G, Reynolds JJ. Extracellular matrix degradation. In: Royce PM, Steinmann B, eds. Connective tissue and its heritable disorders. New York: Wiley-Liss, 1993:287-316.
51. Okada A, Tomasetto C, Lutz Y, Bellocq JP, Rio MC, Basset P. Expression of matrix metalloproteinases during rat skin wound healing; evidence that membrane type-1 matrix metalloproteinase is a stromal activator of pro-gelatinase A. J Cell Biol 1997;137: 67-77.